Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 201–300 of 1,008
Organoid models of gastrointestinal cancers in basic and translational research
Lau, H. C. H., Kranenburg, O., Xiao, H., & Yu, J. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0255-2 · Cited by 194
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Belhabib, I., Zaghdoudi, S., Lac, C., Bousquet, C., & Jean, C. (2021) · Cancers · doi:10.3390/cancers13143466 · Cited by 191
The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
Sun, Q., Zhang, B., Hu, Q., Qin, Y., Xu, W., Liu, W., Yu, X., & Xu, J. (2018) · Theranostics · doi:10.7150/thno.26546 · Cited by 193
Gorchs, L., Fernández Moro, C., Bankhead, P., Kern, K. P., Sadeak, I., Meng, Q., Rangelova, E., & Kaipe, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00847 · Cited by 193
KRAS drives immune evasion in a genetic model of pancreatic cancer
Ischenko, I., D’Amico, S., Rao, M., Li, J., Hayman, M. J., Powers, S., Petrenko, O., & Reich, N. C. (2021) · Nature Communications · doi:10.1038/s41467-021-21736-w · Cited by 191
Olbrecht, S., Busschaert, P., Qian, J., Vanderstichele, A., Loverix, L., Van Gorp, T., Van Nieuwenhuysen, E., Han, S., Van den Broeck, A., Coosemans, A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00922-x · Cited by 192
Pein, M., Insua-Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., Decker, K., Essers, M. A. G., Sinn, H.-P., Spaich, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15188-x · Cited by 191
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy
Huseni, M. A., Wang, L., Klementowicz, J. E., Yuen, K., Breart, B., Orr, C., Liu, L.-F., Li, Y., Gupta, V., Li, C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100878 · Cited by 188
Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers
Wright, K., Ly, T., Kriet, M., Czirok, A., & Thomas, S. M. (2023) · Cancers · doi:10.3390/cancers15061899 · Cited by 187
The Pancreatic Cancer Microenvironment
Dougan, S. K. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000288 · Cited by 187
The advent of immune stimulating CAFs in cancer
Tsoumakidou, M. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00549-7 · Cited by 185
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
Geng, X., Chen, H., Zhao, L., Hu, J., Yang, W., Li, G., Cheng, C., Zhao, Z., Zhang, T., Li, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655152 · Cited by 185
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
Adamska, A., Elaskalani, O., Emmanouilidi, A., Kim, M., Abdol Razak, N. B., Metharom, P., & Falasca, M. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.007 · Cited by 183
The tumor microenvironment’s role in the response to immune checkpoint blockade
Aliazis, K., Christofides, A., Shah, R., Yeo, Y. Y., Jiang, S., Charest, A., & Boussiotis, V. A. (2025) · Nature Cancer · doi:10.1038/s43018-025-00986-3 · Cited by 178
MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
Sodir, N. M., Kortlever, R. M., Barthet, V. J. A., Campos, T., Pellegrinet, L., Kupczak, S., Anastasiou, P., Swigart, L. B., Soucek, L., Arends, M. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0435 · Cited by 182
Applications of organoids for cancer biology and precision medicine
Lo, Y.-H., Karlsson, K., & Kuo, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0102-y · Cited by 182
Munir, H., Jones, J. O., Janowitz, T., Hoffmann, M., Euler, M., Martins, C. P., Welsh, S. J., & Shields, J. D. (2021) · Nature Communications · doi:10.1038/s41467-021-20982-2 · Cited by 178
Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis
Messal, H. A., Alt, S., Ferreira, R. M. M., Gribben, C., Wang, V. M.-Y., Cotoi, C. G., Salbreux, G., & Behrens, A. (2019) · Nature · doi:10.1038/s41586-019-0891-2 · Cited by 178
Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives
Miyai, Y., Esaki, N., Takahashi, M., & Enomoto, A. (2020) · Cancer Science · doi:10.1111/cas.14346 · Cited by 177
Datta, J., Dai, X., Bianchi, A., De Castro Silva, I., Mehra, S., Garrido, V. T., Lamichhane, P., Singh, S. P., Zhou, Z., Dosch, A. R., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.07.076 · Cited by 178
Yan, Y., Sun, D., Hu, J., Chen, Y., Sun, L., Yu, H., Xiong, Y., Huang, Z., Xia, H., Zhu, X., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-01998-y · Cited by 170
Djurec, M., Graña, O., Lee, A., Troulé, K., Espinet, E., Cabras, L., Navas, C., Blasco, M. T., Martín-Díaz, L., Burdiel, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717802115 · Cited by 178
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Lin, J. H., Huffman, A. P., Wattenberg, M. M., Walter, D. M., Carpenter, E. L., Feldser, D. M., Beatty, G. L., Furth, E. E., & Vonderheide, R. H. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190673 · Cited by 178
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
Bughda, R., Dimou, P., D'Souza, R. R., & Klampatsa, A. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s291767 · Cited by 172
Cellular senescence and the tumour microenvironment
Takasugi, M., Yoshida, Y., & Ohtani, N. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13268 · Cited by 172
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Proietto, M., Crippa, M., Damiani, C., Pasquale, V., Sacco, E., Vanoni, M., & Gilardi, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164535 · Cited by 172
Spada, S., Tocci, A., Di Modugno, F., & Nisticò, P. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01908-8 · Cited by 172
Bhagat, T. D., Von Ahrens, D., Dawlaty, M., Zou, Y., Baddour, J., Achreja, A., Zhao, H., Yang, L., Patel, B., Kwak, C., et al. (2019) · eLife · doi:10.7554/elife.50663 · Cited by 173
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
Dzobo, K., & Dandara, C. (2023) · Biomimetics · doi:10.3390/biomimetics8020146 · Cited by 171
Govindaraju, P., Todd, L., Shetye, S., Monslow, J., & Puré, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.06.004 · Cited by 170
Hydrogel-based colorectal cancer organoid co-culture models
Luo, X., Fong, E. L. S., Zhu, C., Lin, Q. X. X., Xiong, M., Li, A., Li, T., Benoukraf, T., Yu, H., & Liu, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.037 · Cited by 170
Wang, H., Li, N., Liu, Q., Guo, J., Pan, Q., Cheng, B., Xu, J., Dong, B., Yang, G., Yang, B., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.016 · Cited by 171
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Croizer, H., Mhaidly, R., Kieffer, Y., Gentric, G., Djerroudi, L., Leclere, R., Pelon, F., Robley, C., Bohec, M., Meng, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47068-z · Cited by 164
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression
Ye, J., Baer, J. M., Faget, D. V., Morikis, V. A., Ren, Q., Melam, A., Delgado, A. P., Luo, X., Bagchi, S. M., Belle, J. I., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0426 · Cited by 164
Tiriac, H., Bucobo, J. C., Tzimas, D., Grewel, S., Lacomb, J. F., Rowehl, L. M., Nagula, S., Wu, M., Kim, J., Sasson, A., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.12.032 · Cited by 164
Self-citationSomatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Fujii, M., & Sato, T. (2021) · Nature Materials · doi:10.1038/s41563-020-0754-0 · Cited by 165
Organoids to model liver disease
Nuciforo, S., & Heim, M. H. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2020.100198 · Cited by 164
Schuth, S., Le Blanc, S., Krieger, T. G., Jabs, J., Schenk, M., Giese, N. A., Büchler, M. W., Eils, R., Conrad, C., & Strobel, O. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02519-7 · Cited by 156
Barriers and opportunities in pancreatic cancer immunotherapy
Ju, Y., Xu, D., Liao, M.-M., Sun, Y., Bao, W.-D., Yao, F., & Ma, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00681-z · Cited by 159
Chronic Inflammation and Blood CancerPreprint
Tzenios, N., Tazanios, M., & Chahine, M. A. (2022) · Preprints.org · doi:10.20944/preprints202211.0365.v2 · Cited by 161
Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán, J., & Matic Vignjevic, D. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.09.002 · Cited by 160
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
De Jaeghere, E. A., Denys, H. G., & De Wever, O. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.09.009 · Cited by 160
Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Strell, C., Paulsson, J., Jin, S.-B., Tobin, N. P., Mezheyeuski, A., Roswall, P., Mutgan, C., Mitsios, N., Johansson, H., Wickberg, S. M., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy234 · Cited by 158
Zhang, F., Ma, Y., Li, D., Wei, J., Chen, K., Zhang, E., Liu, G., Chu, X., Liu, X., Liu, W., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01600-2 · Cited by 211
Rai, A., Greening, D. W., Chen, M., Xu, R., Ji, H., & Simpson, R. J. (2019) · PROTEOMICS · doi:10.1002/pmic.201800148 · Cited by 157
Deoxycytidine release from pancreatic stellate cells promotes gemcitabine resistance
Dalin, S., Sullivan, M. R., Lau, A. N., Grauman-Boss, B., Mueller, H. S., Kreidl, E., Fenoglio, S., Luengo, A., Lees, J. A., Vander Heiden, M. G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0960 · Cited by 156
Glaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 182
Self-citationCarcinogenesis of Pancreatic Ductal Adenocarcinoma
Storz, P., & Crawford, H. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.059 · Cited by 154
Korbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 173
Elahi-Gedwillo, K. Y., Carlson, M., Zettervall, J., & Provenzano, P. P. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1334 · Cited by 153
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
Efthymiou, G., Saint, A., Ruff, M., Rekad, Z., Ciais, D., & Obberghen‐Schilling, E. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00641 · Cited by 164
Jeong, H. Y., Ham, I.-H., Lee, S. H., Ryu, D., Son, S.-Y., Han, S.-U., Kim, T.-M., & Hur, H. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0792 · Cited by 176
Duperret, E. K., Trautz, A., Ammons, D., Perales-Puchalt, A., Wise, M. C., Yan, J., Reed, C., & Weiner, D. B. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2033 · Cited by 152
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00821-z · Cited by 148
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Gaggar, S., & Gögenur, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668731 · Cited by 150
Barriers and opportunities for gemcitabine in pancreatic cancer therapy
Beutel, A. K., & Halbrook, C. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2022 · Cited by 150
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 183
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
Louault, K., Li, R.-R., & DeClerck, Y. A. (2020) · Cancers · doi:10.3390/cancers12113108 · Cited by 148
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
Kadomoto, S., Izumi, K., & Mizokami, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168530 · Cited by 145
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Cancer-associated fibroblasts: how do they contribute to metastasis?
Kwa, M. Q., Herum, K. M., & Brakebusch, C. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09959-0 · Cited by 168
Organoids in gastrointestinal diseases: From experimental models to clinical translation
Günther, C., Winner, B., Neurath, M. F., & Stappenbeck, T. S. (2022) · Gut · doi:10.1136/gutjnl-2021-326560 · Cited by 145
Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
Sharick, J. T., Walsh, C. M., Sprackling, C. M., Pasch, C. A., Pham, D. L., Esbona, K., Choudhary, A., Garcia-Valera, R., Burkard, M. E., McGregor, S. M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00553 · Cited by 142
Monteran, L., Ershaid, N., Doron, H., Zait, Y., Scharff, Y., Ben-Yosef, S., Avivi, C., Barshack, I., Sonnenblick, A., & Erez, N. (2022) · Nature Communications · doi:10.1038/s41467-022-33598-x · Cited by 144
Xue, M., Zhu, Y., Jiang, Y., Han, L., Shi, M., Su, R. J., Wang, L., Xiong, C., Wang, C., Wang, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40314-w · Cited by 165
Perez, V. M., Kearney, J. F., & Yeh, J. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751311 · Cited by 143
Hu, C., Xia, R., Zhang, X., Li, T., Ye, Y., Li, G., He, R., Li, Z., Lin, Q., Zheng, S., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01501-3 · Cited by 156
Lai, B. F. L., Lu, R. X. Z., Hu, Y., Davenport Huyer, L., Dou, W., Wang, E. Y., Radulovich, N., Tsao, M. S., Sun, Y., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000545 · Cited by 142
The remodelling of actin composition as a hallmark of cancer
Suresh, R., & Diaz, R. J. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101051 · Cited by 158
Schwörer, S., Cimino, F. V., Ros, M., Tsanov, K. M., Ng, C., Lowe, S. W., Carmona‐Fontaine, C., & Thompson, C. B. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2316 · Cited by 160
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136760 · Cited by 127
Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
Fujii, M., Clevers, H., & Sato, T. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.048 · Cited by 140
Self-citationTargeting Pancreatic Stellate Cells in Cancer
Schnittert, J., Bansal, R., & Prakash, J. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.01.001 · Cited by 159
Yamamoto, Y., Kasashima, H., Fukui, Y., Tsujio, G., Yashiro, M., & Maeda, K. (2022) · Cancer Science · doi:10.1111/cas.15609 · Cited by 170
Koncina, E., Nurmik, M., Pozdeev, V. I., Gilson, C., Tsenkova, M., Begaj, R., Stang, S., Gaigneaux, A., Weindorfer, C., Rodriguez, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39953-w · Cited by 160
Fu, Y., Liu, S., Zeng, S., & Shen, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0815-z · Cited by 138
Bianchi, A., Silva, I. D. C., Deshpande, N., Singh, S. P., Mehra, S., Garrido, V. T., Guo, X., Nivelo, L. A., Kolonias, D. S., Saigh, S. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1046 · Cited by 156
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets
Whittle, M. C., & Hingorani, S. R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.044 · Cited by 137
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Wang, Z., Tang, Y., Tan, Y., Wei, Q., & Yu, W. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0362-2 · Cited by 135
Patient-derived organoid models help define personalized management of gastrointestinal cancer
Aberle, M. R., Burkhart, R. A., Tiriac, H., Olde Damink, S. W. M., Dejong, C. H. C., Tuveson, D. A., & van Dam, R. M. (2018) · British Journal of Surgery · doi:10.1002/bjs.10726 · Cited by 135
Self-citationCancer-associated fibroblasts: The chief architect in the tumor microenvironment
Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 165
The biological underpinnings of therapeutic resistance in pancreatic cancer
Beatty, G. L., Werba, G., Lyssiotis, C. A., & Simeone, D. M. (2021) · Genes & Development · doi:10.1101/gad.348523.121 · Cited by 157
Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Acquired resistance in cancer: towards targeted therapeutic strategies
Soragni, A., Knudsen, E. S., O’Connor, T. N., Tognon, C. E., Tyner, J. W., Gini, B., Kim, D., Bivona, T. G., Zang, X., Witkiewicz, A. K., et al. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00824-9 · Cited by 178
Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., Holst, J., Boyer, C. A., Erkan, M., Goldstein, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2496 · Cited by 144
The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
Senthebane, D., Jonker, T., Rowe, A., Thomford, N., Munro, D., Dandara, C., Wonkam, A., Govender, D., Calder, B., Soares, N., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102861 · Cited by 131
A Wnt-Induced Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits EMT in Colorectal Cancer
Mosa, M. H., Michels, B. E., Menche, C., Nicolas, A. M., Darvishi, T., Greten, F. R., & Farin, H. F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0263 · Cited by 130
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages
Kemp, S. B., Steele, N. G., Carpenter, E. S., Donahue, K. L., Bushnell, G. G., Morris, A. H., The, S., Orbach, S. M., Sirihorachai, V. R., Nwosu, Z. C., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000935 · Cited by 129
Guo, T., & Xu, J. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10186-7 · Cited by 158
Classifying cancer-associated fibroblasts—The good, the bad, and the target
Cords, L., de Souza, N., & Bodenmiller, B. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.011 · Cited by 149
Forsthuber, A., Aschenbrenner, B., Korosec, A., Jacob, T., Annusver, K., Krajic, N., Kholodniuk, D., Frech, S., Zhu, S., Purkhauser, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53908-9 · Cited by 155
Lee, J. J., Bernard, V., Semaan, A., Monberg, M. E., Huang, J., Stephens, B. M., Lin, D., Rajapakshe, K. I., Weston, B. R., Bhutani, M. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3925 · Cited by 128
Glycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 142
Role of the complement system in the tumor microenvironment
Zhang, R., Liu, Q., Li, T., Liao, Q., & Zhao, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1027-3 · Cited by 145
Gu, X., Zhu, Y., Su, J., Wang, S., Su, X., Ding, X., Jiang, L., Fei, X., & Zhang, W. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103209 · Cited by 148
Extracellular matrix anisotropy is determined by TFAP2C-dependent regulation of cell collisions
Park, D., Wershof, E., Boeing, S., Labernadie, A., Jenkins, R. P., George, S. L., Trepat, X., Bates, P. A., & Sahai, E. A. (2019) · Nature Materials · doi:10.1038/s41563-019-0504-3 · Cited by 130
Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
Ganguly, D., Chandra, R., Karalis, J. D., Teke, M. E., Aguilera, T. A., Maddipati, R., Wachsmann, M., Ghersi, D., Siravegna, G., Zeh, H. J., et al. (2020) · Cancers · doi:10.3390/cancers12092652 · Cited by 134
Wong, H. Y., Sheng, Q., Hesterberg, A. B., Croessmann, S., Rios, B. L., Giri, K. R., Jackson, J., Miranda, A. X., Watkins, E., Schaffer, K. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33780-1 · Cited by 142
Norton, J., Foster, D., Chinta, M., Titan, A., & Longaker, M. (2020) · Cancers · doi:10.3390/cancers12051347 · Cited by 125
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.